HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China
· Delayed Price · Currency is CNY 7.20
-0.01 (-0.14%)
Apr 25, 2025, 2:45 PM CST
SHA:600829 Revenue
HPGC Renmintongtai Pharmaceutical had revenue of 2.67B CNY in the quarter ending March 31, 2025, with 2.65% growth. This brings the company's revenue in the last twelve months to 10.12B, down -2.11% year-over-year. In the year 2024, HPGC Renmintongtai Pharmaceutical had annual revenue of 10.05B, down -3.29%.
Revenue (ttm)
10.12B
Revenue Growth
-2.11%
P/S Ratio
0.41
Revenue / Employee
3.53M
Employees
2,870
Market Cap
4.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.05B | -341.70M | -3.29% |
| Dec 31, 2023 | 10.39B | 748.89M | 7.77% |
| Dec 31, 2022 | 9.64B | 325.86M | 3.50% |
| Dec 31, 2021 | 9.32B | 1.31B | 16.36% |
| Dec 31, 2020 | 8.01B | -348.62M | -4.17% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.77B |
| Aier Eye Hospital Group | 20.98B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |